Abstract
In recipients of hematopoietic stem cell transplants (HSCTs), BK virus (BKV) has been associated with late-onset hemorrhagic cystitis (HC). In our institution, HSCT recipients with BKV-associated HC are treated with 1 mg/kg of cidofovir weekly. We identified HSCT recipients with BKV-associated HC, treated with weekly cidofovir. Microbiological response was defined as at least a one log reduction in urinary BKV viral load; clinical response was defined as improvement in symptoms and stability or reduction in the grade of cystitis. Nineteen allogeneic HSCT patients received a mean of 4.5 weekly doses of cidofovir. HC occurred at a mean of 68.7 days after transplant. A clinical response was detected in 16/19 (84%) patients, and 9/19 (47%) had a measurable microbiological response (8/10 nonresponders had a BKV viral load above the upper limit of the assay before treatment). Fourteen out of nineteen (74%) patients had no significant increase in serum creatinine. Five patients with renal dysfunction resolved after completion of the therapy and removal of other nephrotoxic agents. We conclude that weekly low-dose cidofovir appears to be a safe treatment option for BKV-associated HC. Although the efficacy of low-dose cidofovir is not proven, a prospective trial is warranted.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hirsch HH . BK virus: opportunity makes a pathogen. Clin Infect Dis 2005; 41: 354–360.
Arthur RR, Shah KV, Baust SJ, Santos GW, Saral R . Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 1986; 315: 230–234.
Cesaro S, Brugiolo A, Faraci M, Uderzo C, Rondelli R, Favre C et al. Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: a survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group. Bone Marrow Transplant 2003; 32: 925–931.
Gonzalez-Fraile MI, Canizo C, Caballero D, Hernandez R, Vazquez L, Lopez C et al. Cidofovir treatment of human polyomavirus-associated acute haemorrhagic cystitis. Transpl Infect Dis 2001; 3: 44–46.
Gorczynska E, Turkiewicz D, Rybka K, Toporski J, Kalwak K, Dyla A et al. Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2005; 11: 797–804.
Leung AY, Suen CK, Lie AK, Liang RH, Yuen KY, Kwong YL . Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 2001; 98: 1971–1978.
Leung AY, Chan MT, Yuen KY, Cheng VC, Chan KH, Wong CL et al. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2005; 40: 528–537.
Bogdanovic G, Priftakis P, Giraud G, Kuzniar M, Ferraldeschi R, Kokhaei P et al. Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation. J Clin Microbiol 2004; 42: 5394–5396.
Azzi A, Cesaro S, Laszlo D, Zakrzewska K, Ciappi S, De Santis R et al. Human polyoma virus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients. J Clin Virol 1999; 14: 79–86.
Erard V, Kim HW, Corey L, Limaye A, Huang ML, Myerson D et al. BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Blood 2005; 106: 1130–1132.
De Clercq E . In search of a selective antiviral chemotherapy. Clin Microbiol Rev 1997; 10: 674–693.
Andrei G, Snoeck R, Vandeputte M, De Clercq E . Activities of various compounds against murine and primate polyomaviruses. Antimicrob Agents Chemother 1997; 41: 587–593.
Kuypers DR, Vandooren AK, Lerut E, Evenepoel P, Claes K, Snoeck R et al. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant 2005; 5: 1997–2004.
Ramos E, Drachenberg CB, Portocarrero M, Wali R, Klassen DK, Fink JC et al. BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program. Clin Transpl 2002, 143–153.
Tong CY, Hilton R, MacMahon EM, Brown L, Pantelidis P, Chrystie IL et al. Monitoring the progress of BK virus associated nephropathy in renal transplant recipients. Nephrol Dial Transplant 2004; 19: 2598–2605.
Vats A, Shapiro R, Randhawa P, Scantlebury V, Tuzuner A, Saxena M et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 2003; 75: 106–112.
Hatakeyama N, Suzuki N, Kudoh T, Hori T, Mizue N, Tsutsumi H . Successful cidofovir treatment of adenovirus-associated hemorrhagic cystitis and renal dysfunction after allogenic bone marrow transplant. Pediatr Infect Dis J 2003; 22: 928–929.
Palandri F, Bonifazi F, Rossi C, Falcioni S, Arpinati M, Giannini MB et al. Successful treatment of severe hemorrhagic cystitis with selective vesical artery embolization. Bone Marrow Transplant 2005; 35: 529–530.
Held TK, Biel SS, Nitsche A, Kurth A, Chen S, Gelderblom HR et al. Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir. Bone Marrow Transplant 2000; 26: 347–350.
Bedi A, Miller CB, Hanson JL, Goodman S, Ambinder RF, Charache P et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995; 13: 1103–1109.
Cundy K, Petty B, Flaherty J, Fisher P, Polis M, Wachsman M et al. Clinical pharmacokinetics of cidofovir in HIV infected patients. Antimicrob Agents Chemother 1995; 39: 1247–1252.
Lalezari J, Drew W, Glutzer E, James C, Miner D, Flaherty J et al. HPMPC: results of a phase I/II study of a novel nucleotide analogue. J Infect D 1995; 171: 788–796.
Lalezari J, Stagg R, Kupperman B, Holland G, Kramer F, Ives D et al. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 1997; 126: 257–263.
Wachsman M, Petty B, Cundy K, Jaffe H, Fisher P, Pastelak A et al. Pharmacokinetics, safety, and bioavailability of cidofovir in HIV infected subjects. Antiviral Res 1996; 29: 153–161.
Wolf D, Rodriquez C, Mucci M, Ingrosso A, Duncan B, Nickens D . Pharmacokinetics and renal effects of cidofovir with reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis. J Clin Pharmacol 2003; 43: 43–51.
Bridges B, Donegan S, Badros A . Cidofovir bladder instillation for the treatment of BK hemorrhagic cystitis after allogeneic stem cell transplantation. Am J Hematol 2006; 81: 535–537.
Fanourgiakis P, Georgala A, Vekemans M, Triffet A, De Bruyn JM, Duchateau V et al. Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient. Clin Infect Dis 2005; 40: 199–201.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Savona, M., Newton, D., Frame, D. et al. Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. Bone Marrow Transplant 39, 783–787 (2007). https://doi.org/10.1038/sj.bmt.1705678
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705678
Keywords
This article is cited by
-
Review of Intravesicular Cidofovir for BK Virus Hemorrhagic Cystitis
Current Treatment Options in Infectious Diseases (2021)
-
Effectiveness of hyperbaric oxygen therapy for virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation
International Journal of Hematology (2021)
-
Intravesical cidofovir application in BK virus cystitis after allogeneic hematopoetic stem cell transplantation (HSCT) is safe and highly effective
Bone Marrow Transplantation (2018)